HR4392-118

Introduced

To increase access to pre-exposure prophylaxis to reduce the transmission of HIV.

118th Congress Introduced Jun 27, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To increase access to pre-exposure prophylaxis to reduce the transmission of HIV., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Social Welfare.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H9C974BEB4D9B4A17BD8523C26086F818: 1. Short title This Act may be cited as the PrEP Access and Coverage Act of 2023.
  • Section H61C9E13F51CE47CCA7DC480BB4654691: 2. Findings; sense of Congress Congress finds the following: The Centers for Disease Control and Prevention estimates that approximately 1,200,000 individuals...
  • Section H8F45B03523624267BCD8B1BB353D94DF: 3. Coverage of HIV testing and prevention services Section 2713(a) of the Public Health Service Act (42 U.S.C. 300gg–13(a)) is amended— in paragraph (2), by...
  • Section HFE4D479F18DF4847A4C2B07592758B30: 2729A. Prohibition on preauthorization requirements with respect to certain services A group health plan or a health insurance issuer offering group or...
  • Section H3B797A8373B646259C8032A0728F7F28: 1074p. Coverage of HIV prevention treatment The Secretary of Defense shall ensure coverage under the TRICARE program of HIV prevention treatment described in...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To increase access to pre-exposure prophylaxis to reduce the transmission of HIV., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Government Operations, Social Welfare

Primary Purpose

This bill, To increase access to pre-exposure prophylaxis to reduce the transmission of HIV., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Government Operations Social Welfare

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

Introduced
Introduced Committee Passed
Jun 27, 2023

Mr. Schiff (for himself, Mr. Bera, Mr. Beyer, Mr. Bowman, …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Government Operations Social Welfare
Actor Mappings
"the_commission"
→ The commission identified in the operative section
"the_administrator"
→ The Administrator identified in the operative section
"secretary_of_labor"
→ Secretary of Labor
"secretary_of_defense"
→ Secretary of Defense
"secretary_of_treasury"
→ Secretary of the Treasury
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

Key Definitions

Terms defined in this bill

2 terms
"PEP" §HB516D752E4F94085AA0C5DF35074DBAC

any drug or combination of drugs approved by the Food and Drug Administration for preventing HIV transmission after a sexual or other exposure associated with a high risk of HIV transmission

"PEP" §HCC7C3F9B152840F1BC6119E224F338B4

any drug or combination of drugs approved by the Food and Drug Administration for preventing HIV transmission after a sexual or other exposure associated with a high risk of HIV transmission

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology